Prophase Labs Inc PRPH:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
7.72quote price arrow down-0.46 (-5.62%)
Volume
139,928
52 week range
1.20 - 16.04

...

Loading . . .

KEY STATS

  • Open8.49
  • Day High8.50
  • Day Low7.60
  • Prev Close8.18
  • 52 Week High16.04
  • 52 Week High Date01/15/21
  • 52 Week Low1.20
  • 52 Week Low Date06/26/20
  • Market Cap116.96M
  • Shares Out15.15M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta-0.01
  • 1 Year % Change341.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.15
  • P/E (TTM)-51.54
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.437M
  • ROE (MRQ)-13.79%
  • Revenue (MRQ)12.49M
  • Gross Margin (MRQ)29.91%
  • Net Margin (MRQ)-13.89%
  • Debt To Equity (MRQ)92.84%

EVENTS

  • Earnings Date-
  • Ex Div Date12/02/2019
  • Div Amount0.25
  • Split Date-
  • Split Factor-

Latest Prophase Labs Inc News

There is no recent news for this security.

Latest PRPH News From Our Partners

QUOTE FINDER

Profile

MORE
ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and...
Ted Karkus
Chairman
Monica Brady
Chief Financial Officer
Address
711 STEWART AVENUE, GARDEN CITY
New York, NY
11530
United States